Epigenomics AG / Key word(s): Conference 10.12.2014 / 09:30 Epigenomics to present at the Oppenheimer 25th Annual Healthcare Conference Berlin (Germany) and Germantown, MD (U.S.A.), December 10, 2014 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY), the German-American cancer molecular diagnostics company, today announced that CEO/CFO Dr. Thomas Taapken will be presenting at the […]
Year: 2014
10. December 2014
Epigenomics AG: Epigenomics to present at the Oppenheimer 25th Annual Healthcare Conference
Read more
08. December 2014
Ad hoc Announcement Pursuant to § 15 WpHG (German Securities Trading Act): Epigenomics and BioChain Announce Approval of Epi proColon(R) in China
Epigenomics AG / Key word(s): Regulatory Approval/Miscellaneous 08.12.2014 08:05 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP – a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. ————————————————————————— Berlin (Germany), Germantown, MD, and Newark, CA (U.S.A.), Beijing (China), December 08, 2014 […]
08. December 2014
Epigenomics AG: Epigenomics and BioChain Announce Approval of Epi proColon(R) in China
Epigenomics AG / Key word(s): Regulatory Approval 08.12.2014 / 08:05 Epigenomics and BioChain Announce Approval of Epi proColon(R) in China Berlin (Germany), Germantown, MD, and Newark, CA (U.S.A.) and Beijing (China), December 08, 2014 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY), the German-American cancer molecular diagnostics company, and BioChain, a leading clinical diagnostics […]
28. November 2014
Epigenomics AG: Veröffentlichung der Gesamtzahl der Stimmrechte nach § 26a WpHG mit dem Ziel der europaweiten Verbreitung
Epigenomics AG / Veröffentlichung der Gesamtzahl der Stimmrechte 28.11.2014 16:30 Veröffentlichung der Gesamtzahl der Stimmrechte nach § 26a WpHG, übermittelt durch DGAP – ein Service der EQS Group AG. Für den Inhalt der Mitteilung ist der Emittent verantwortlich. ————————————————————————— Hiermit teilt die Epigenomics AG mit, dass die Gesamtzahl der Stimmrechte am Ende des Monats November […]
11. November 2014
Epigenomics AG: Epigenomics AG Announces 2014 Third Quarter and Nine Month Financial Results and Reports on Operational Highlights
Epigenomics AG / Key word(s): 9-month figures 11.11.2014 / 08:30 Epigenomics AG Announces 2014 Third Quarter and Nine Month Financial Results and Reports on Operational Highlights Berlin (Germany) and Germantown, MD (U.S.A.), November 11, 2014 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY), the German-American cancer molecular diagnostics company, today announced its financial results […]
03. November 2014
Epigenomics AG: Epigenomics’ strategic commercialization partner Polymedco reiterates its commitment to support Epi proColon(R) in the United States
Epigenomics AG / Key word(s): Alliance 03.11.2014 / 10:34 Epigenomics’ strategic commercialization partner Polymedco reiterates its commitment to support Epi proColon(R) in the United States Berlin (Germany) and Germantown, MD (USA), November 03, 2014 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY), the German-American cancer molecular diagnostics company, today announced that Polymedco, Inc., a […]